Results of the HIDIT-2 trial

Please find here (Physician & Scientists / Download section) the presentation of the HIDIT-II trial results presented at the International Liver Congress in London 2014

A multicenter randomized study comparing the efficacy of pegylated interferon-alfa-2a plus placebo vs. pegylated interferon-alfa-2a plus tenofovir for the treatment of chronic delta hepatitis –

The Hep-Net International Delta Hepatitis Interventional Trial II (HIDIT-II)

Comments

No one has commented on this page yet.

Post your comment

Published

02. May 2014
0 Comments